- By Ben Shepherd
- FDA, vaccine
Goldman Sachs expects the FDA to approve a vaccine this year, according to senior economist Daan Struyven. Right now, there are 26 vaccines in clinical trials. More than a dozen […]
Latest Daily Profit
- By Ian Wyatt
It won’t be easy to pass another round of economic stimulus. “Half the Republicans are going to vote no to any phase 4 package, that’s just a fact,” says Sen. […]
The next big stimulus bill is underway. Republicans in the house are scrambling to rollout the next phase of stimulus to support the U.S. economy. Treasury Secretary Steve Mnuchin claims […]
- By Ben Shepherd
Analysts have been predicting that the coronavirus would destroy second quarter earnings. And many predicted that earnings would fall 40% or more in the quarter. The second quarter has produced […]
The U.S. government is pulling out the stops. Today the Department of Health & Human Services agreed to buy millions of new Covid-19 vaccines. The initial order includes 100 million […]
America’s economy is bouncing back. That’s why the S&P 500 jumped 45% in the last four-months. This big move for the market preceded the strong recovery for America’s economy from […]
Investors are getting nervous about U.S. stocks as the coronavirus recession lingers. Even some notable bulls are suggesting you should get out of U.S. stocks. Learn more about a trading […]
$3,800. That’s the newest and biggest share price target for Amazon shares (NASDAQ: AMZN). The target price represents a 27% increase from the recent share price. Yet smart investors could […]
Three new and promising Covid-19 vaccines are emerging. Oxford University is producing a vaccine in partnership with AstraZeneca (NYSE: AZN). The drug is already in Phase III vaccine trials in […]
Covid cases are spreading like a California wildfire. 75,600 new Covid cases were reported across the U.S. on Thursday. And that number shattered the previous coronavirus record of 68,241 cases. […]